AR101731A1 - DIMMED BOVINE CORONAVIRUS AND RELATED VACCINES - Google Patents
DIMMED BOVINE CORONAVIRUS AND RELATED VACCINESInfo
- Publication number
- AR101731A1 AR101731A1 ARP150102793A ARP150102793A AR101731A1 AR 101731 A1 AR101731 A1 AR 101731A1 AR P150102793 A ARP150102793 A AR P150102793A AR P150102793 A ARP150102793 A AR P150102793A AR 101731 A1 AR101731 A1 AR 101731A1
- Authority
- AR
- Argentina
- Prior art keywords
- dimmed
- bovine coronavirus
- related vaccines
- bovine
- bcov
- Prior art date
Links
- 241000711443 Bovine coronavirus Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000283690 Bos taurus Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Reivindicación 1: Un coronavirus bovino atenuado (BCoV) que codifica una proteína de púa que tiene 95% o más de identidad con la secuencia de aminoácidos de SEC. ID. Nº 2. Reivindicación 14: Una vacuna que comprende el BCoV de la reivindicación 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, ó 13. Reivindicación 25: Un método de vacunación de un bovino, que comprende la administración de la vacuna de la reivindicación 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, ó 24.Claim 1: An attenuated bovine coronavirus (BCoV) encoding a barbed protein that has 95% or more identity with the amino acid sequence of SEC. ID. No. 2. Claim 14: A vaccine comprising the BCoV of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, or 13. Claim 25: A method of vaccination of a bovine, comprising administration of the vaccine of claim 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462045183P | 2014-09-03 | 2014-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR101731A1 true AR101731A1 (en) | 2017-01-11 |
Family
ID=58698675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102793A AR101731A1 (en) | 2014-09-03 | 2015-09-01 | DIMMED BOVINE CORONAVIRUS AND RELATED VACCINES |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR101731A1 (en) |
-
2015
- 2015-09-01 AR ARP150102793A patent/AR101731A1/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX373792B (en) | CORONAVIRUS. | |
| MX2022011934A (en) | IMMUNOMODULATORY THERAPEUTIC mRNA COMPOSITIONS THAT ENCODE ACTIVATION ONCOGENE MUTATION PEPTIDES. | |
| ES2722773T3 (en) | Modified Meningococcal fHbp Polypeptides | |
| PH12020500080A1 (en) | Senecavirus a immunogenic compositions and methods thereof | |
| ES2721309T3 (en) | Composition for preparing tagatose and method for preparing tagatose from fructose | |
| AR100238A1 (en) | METHOD FOR PRODUCING L-AMINO ACIDS IN CORINEBACTERIA THROUGH THE USE OF A GLYCINE SCISION SYSTEM | |
| EP4516907A3 (en) | Methods of making and using universal centralized influenza vaccine genes | |
| EA201890527A1 (en) | THERAPEUTIC VACCINES AGAINST HPV18 | |
| MX386234B (en) | MALARIA VACCINE. | |
| CL2016002794A1 (en) | Peptide vaccine comprising a mutant ras peptide and a chemotherapeutic agent | |
| EA201790787A1 (en) | REDUCTION OF VISCOSITY OF PHARMACEUTICAL COMPOSITIONS | |
| AR120721A2 (en) | PEPTIDES AND COMPOSITIONS FOR THE TREATMENT OF JOINT DAMAGE | |
| PH12020500569A1 (en) | Influenza virus vaccines and uses thereof | |
| TW201612190A (en) | Flavivirus virus like particle | |
| MX390304B (en) | PROCESS FOR PREPARING AN ATTENUATED TETRAVALENT VACCINE AGAINST DENGUE. | |
| MX379510B (en) | ATTENUATED BOVINE CORONAVIRUS AND RELATED VACCINES. | |
| BR112016016103A2 (en) | COMPOSITION OF MYCOBACTERIAL ANTIGENS | |
| PE20190397A1 (en) | DUCK ENTERITIS VIRUS AND USES OF IT | |
| PH12018501154A1 (en) | Attenuated infectious bronchitis virus | |
| AR108688A1 (en) | YEAST VACCINE VECTOR INCLUDING IMMUNE STIMULATING AND ANTIGEN POLYPEPTIDES, METHODS FOR USE | |
| EA201792512A1 (en) | COMPOSITIONS FOR DELIVERY OF ANTIGENS OF RESPIRATORY SYNTICIAL VIRUS AND NOROVIRUS INTO THE THIN INTESTINE | |
| CY1125031T1 (en) | METHOD FOR GENE THERAPY USING AAV-XBP1S/GFP VIRUS AND USE THEREOF IN THE PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | |
| MX2023003934A (en) | Filovirus consensus antigens, nucleic acid constructs and vacciens made therefrom, and methods of using same. | |
| AR104271A1 (en) | VACCINE AGAINST PAPERAS BASED ON VIRUS JERYL LYNN 2 RECOMBINANT | |
| BR112017006969A2 (en) | hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using the same, immunity inducer and antigen presenting cell production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |